Microplasmin: ex vivo characterization of its activity in porcine vitreous

Marc D de Smet1, Christophe Valmaggia, Javier Zarranz-Ventura

  • 1Department of Ophthalmology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. mddesmet1@mac.com

Abstract

Insights

Microplasmin effectively separates the posterior vitreous in a porcine eye model. This vitreolysis is dose- and time-dependent, with 125 micrograms being the minimum effective dose for posterior vitreous detachment.

Area of Science:

  • Ophthalmology
  • Biochemistry
  • Enzymology

Background:

  • Microplasmin is a recombinant protein containing only the enzymatic part of plasmin.
  • It exhibits enzymatic activity comparable to native plasmin.
  • Understanding its vitreolytic potential is crucial for potential therapeutic applications.

Purpose of the Study:

  • To characterize the vitreolytic ability of microplasmin.
  • To evaluate microplasmin's efficacy in inducing posterior vitreous detachment (PVD) in a porcine eye model.
  • To determine the dose and time dependency of microplasmin's vitreolytic action.

Main Methods:

  • Fresh porcine eyes were used for ex vivo experiments.
  • Eyes were treated with varying doses of microplasmin (62.5–400 µg) for 1 hour or with 125 µg microplasmin for extended durations (15–120 minutes).
  • Vitreous structural integrity and posterior vitreous detachment were assessed using light microscopy and scanning electron microscopy (SEM) after careful dehydration.

Main Results:

  • Posterior hyaloid separation was dose-dependent, with 125 µg achieving 100% detachment at the posterior pole after 1 hour.
  • Higher doses (250 µg) led to midperipheral detachment within 1 hour.
  • Significant changes in vitreous structure were observed without apparent retinal damage on histology or SEM.

Conclusions:

  • Microplasmin induces vitreolysis and posterior vitreous separation in an ex vivo porcine model.
  • The effect is dependent on both the dose and duration of exposure.
  • The minimal effective dose for inducing PVD in this model was determined to be 125 µg.

Related Concept Videos